GH
Gul, Halise Inci
27 papers · 493 citations · 2021–2026
Publications
27
Citations
493
Years
6
Publications
| Title | Year | Type | Citations |
|---|---|---|---|
|
Design, synthesis and QSAR-based antitumor signaling pathway analysis of pyrazoline- benzenesulfonamides mediated by cytostatic G1 arrest
|
2026 | Article | 0 |
|
Synthesis, enzyme inhibition, in silico molecular docking and DFT analysis of novel multi-functionalized thiourea and thiazolidinone benzenesulfonamides
|
2026 | Article | 0 |
|
Microwave-assisted synthesis of indanone-based mannich base derivatives:<i> In</i><i> Silico</i> study, evaluations of dual enzyme inhibition, drug-likeness, cytotoxicity, and selectivity properties (vol 1358, 145363, 2026)
|
2026 | Correction | 0 |
|
Exploring the Structure-Activity Relationship of COX Inhibitors with Anticancer Effects: A Comprehensive Review
|
2025 | Review | 1 |
|
Tumor-specific cytotoxicity of pyrazole-based chalcone derivatives in human oral squamous cell carcinoma cell lines
|
2025 | Article | 0 |
|
Indanone-based Mannich bases: Design, synthesis, in-silico molecular docking, ADME predictions and biological evaluation including carbonic anhydrases, acetylcholinesterase inhibition and cytotoxicities
|
2025 | Article | 13 |
|
Synthesis, Bioactivities, and <i>in Silico</i> Studies of Novel Benzo[<i>d</i>][1,3]Dioxole-Based Pyrazoline Sulfonamides
|
2025 | Article | 5 |
|
Molecular Docking Studies and Biological Activities of Chalcones Targeting Acetylcholinesterase, and Carbonic Anhydrase Isoenzymes
|
2025 | Article | 1 |
|
<i>In Vitro</i> Enzyme Activity and Molecular Docking Studies of Pyrazoline Derivatives as Monoamine Oxidase Inhibitors
|
2024 | Article | 2 |
|
Biological Activities and Drug-Likeness Properties of Phenol-Based Heterocyclic Compounds
|
2024 | Article | 8 |
|
Current Pharmaceutical Research on the Significant Pharmacophore Mannich bases in Drug Design
|
2023 | Review | 11 |
|
Design, synthesis, and assessment of pharmacological properties of indole-based fluorinated chalcones and their benzenesulfonamide analogs
|
2023 | Article | 14 |
|
Higher number of microplastics in tumoral colon tissues from patients with colorectal adenocarcinoma
|
2023 | Article | 85 |
|
Investigation of carbonic anhydrase inhibitory effects and cytotoxicities of pyrazole-based hybrids carrying hydrazone and zinc-binding benzenesulfonamide pharmacophores
|
2022 | Article | 14 |
|
Quinazolinone-based benzenesulfonamides with low toxicity and high affinity as monoamine oxidase-A inhibitors: Synthesis, biological evaluation and induced-fit docking studies
|
2022 | Article | 46 |
|
Monoamine Oxidase (MAO) as a Potential Target for Anticancer Drug Design and Development
|
2021 | Review | 68 |
|
Effects of a Novel Benzenesulfonamide 4-(3-(4-Bromophenyl)-5-(2,4-dimethoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl) on Antioxidant Enzymes and Hematological Parameters of Rainbow Trout (Oncorhynchus mykiss)
|
2021 | Article | 2 |
|
Exploring of tumor-associated carbonic anhydrase isoenzyme IX and XII inhibitory effects and cytotoxicities of the novel <i>N</i>-aryl-1-(4-sulfamoylphenyl)-5-(thiophen-2-yl)-1<i>H</i>-pyrazole-3-carboxamides
|
2021 | Article | 19 |
|
Synthesis and biological evaluation of new pyrazolebenzene-sulphonamides as potential anticancer agents and hCA I and II inhibitors
|
2021 | Article | 10 |
|
Antibacterial and Acetylcholinesterase Inhibitory Potentials of Triazenes Containg Sulfonamide Moiety
|
2021 | Article | 7 |
|
New Chalcone Derivatives with Pyrazole and Sulfonamide Pharmacophores as Carbonic Anhydrase Inhibitors
|
2021 | Article | 18 |
|
Comprehensive study on potent and selective carbonic anhydrase inhibitors: Synthesis, bioactivities and molecular modelling studies of 4-(3-(2-arylidenehydrazine-1-carbonyl)-5-(thiophen-2-yl)-1<i>H</i>-pyrazole-1-yl) benzenesulfonamides
|
2021 | Article | 38 |
|
Docking Studies and Antiproliferative Activities of 6-(3-aryl-2-propenoyl)-2(3<i>H</i>)-benzoxazolone Derivatives as Novel Inhibitors of Phosphatidylinositol 3-Kinase (PI3Kα)
|
2021 | Article | 5 |
|
Biological activities of a newly synthesized pyrazoline derivative 4-(3-(4-bromophenyl)-5-(2,4-dimethoxyphenyl)-4,5-dihydro-1<i>H</i>-pyrazol-1-yl) benzenesulfonamide (B4) compound on rainbow trout alevins, <i>Oncorhynchus mykiss</i>
|
2021 | Article | 4 |
|
Synthesis and in vitro carbonic anhydrases and acetylcholinesterase inhibitory activities of novel imidazolinone-based benzenesulfonamides
|
2021 | Article | 66 |
|
Synthesis of benzamide derivatives with thiourea-substituted benzenesulfonamides as carbonic anhydrase inhibitors
|
2021 | Article | 33 |
|
Phenothiazine-based chalcones as potential dual-target inhibitors toward cholinesterases (AChE, BuChE) and monoamine oxidases (MAO-A, MAO-B)
|
2021 | Article | 23 |